View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Doxorubicin 60 / Cyclophosphamide 600 x 4 followed by Pertuzumab 1200 / Trastuzumab 600 / Docetaxel 100 x 4, Breast Ca, adjuvant, Part B Cycle 1
Protocol-ID: 1751 V1.0 (Mini), AC (DOXO60/CYCL600) x 4 followed by PERT1200/TRAS600/DOCE100 x 4, Breast Ca, adj., B C1Indication(s)
- Breast Cancer (HER2+); ICD-10 C50.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 30.03.2021